Cabaron, Letecia P.

HRN: 22-08-78  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/15/2026
LEVOFLOXACIN 5MG/ML, 100ML (VIAL)
05/15/2026
05/15/2026
IV
500mg
LD
Capmr Cuti
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Urinary TractPneumonia    Compliance to guidelines: Compliant To Guidelines